Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Article Type

    Potential of Traditional Chinese Medicines to treat Drug-resistant Bacterial Infections: A Review

    wadmin1By wadmin1October 8, 2021Updated:October 8, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Ziang Cao1, Ian Edwin Cock1,2,*
    1School of Environment and Science, Griffith University, Nathan, Brisbane, Queensland, AUSTRALIA.
    2Environmental Futures Research Institute, Griffith University, Nathan, Brisbane, Queensland, AUSTRALIA.
    DOI: 10.5530/pc.2021.4.38

    Background: Antibiotic drugs have been widely applied in the treatment of bacterial infections. However, with the overuse and unreasonable adoption of antibiotics, a variety of bacteria have developed resistance to commonly used antibiotics. Bacterial pathogens with multi-drug resistance mechanisms have made many infectious diseases more difficult to be treat and new therapies are urgently needed. Methods: An extensive review of ethnobotanical books, reviews and primary scientific studies was undertaken to identify TCMs used to treat bacterial infections and the individual components of those medicines this information was used to identify gaps in the current research that require further study. Results: Traditional Chinese medicine contain multiple components and function via multiple pathways against multiple targets. Many of these pathways and concepts may be difficult for non-Chinese due to their complexities. However, an evaluation of TCMs for antibacterial activities is an attractive option for antibiotic discovery and development as they generally have low toxicity, low side effects and as combinational therapies, there is no inherent drug resistances in human bacterial pathogens towards these drugs. This study reviews the current status of bacterial resistance, the mechanism of traditional Chinese medicine against bacterial infections, and the adoption progress of Chinese herbal medicines in the treatment of resistant bacterial infections. Conclusion: TCM can inhibit the growth of bacterial pathogens and can participate in mediating the immune function of multiple bodily aspects. Therefore, Chinese herbal medicine may provide new leads to treat drug-resistant bacterial infections.

    Key words: Chinese herbal medicine, Resistant bacteria, Synergy, Combinational therapies, MRSA, ESBL, Bacterial pathogens.

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up